IP Library › Assignment 051730/0213
Patent Assignment
Reel/Frame 051730/0213

Change of Name

Recorded: 2019-09-25 Pages: 7
Assignor
AERPIO THERAPEUTICS, INC.
Executed: 2017-03-15
Assignee
AERPIO THERAPEUTICS LLC
9987 CARVER ROAD, SUITE 420, CINCINNATI, OHIO, 45243
Covered Property (1)
Human Protein Tyrosine Phosphatase Inhibitors and Methods of Use
Patent: 8,895,563 →
Application: 13/936,450 →
Publication: US 2013/0324558
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest May 5, 2014
From: GRAY, JEFFREY LYLE; AMARASINGHE, KANDE K. D.; CLARK, CYNTHIA MONESA; NICHOLS, RYAN MATTHEW
To: AERPIO THERAPEUTICS INC
Reel/Frame 032821/0900 →
Corrective Assignment to Correct the Correct Typographical Error and Add "," After Aerpio Therapeutics and Before Inc. Previously Recorded on Reel 032821 Frame 0900. Assignor(S) Hereby Confirms the Patent Assignment. Sep 19, 2019
From: GRAY, JEFFREY LYLE; CLARK, CYNTHIA MONESA; NICHOLS, RYAN MATTHEW; MAIER, MATTHEW B.
To: AERPIO THERAPEUTICS, INC.
Reel/Frame 050432/0400 →
Assignment of Assignor's Interest Apr 17, 2020
From: AERPIO THERAPEUTICS LLC
To: AERPIO PHARMACEUTICALS, INC.
Reel/Frame 052432/0789 →
Assignment of Assignor's Interest Sep 9, 2021
From: AERPIO PHARMACEUTICALS, INC.
To: EYEPOINT PHARMACEUTICALS, INC.
Reel/Frame 057448/0033 →